FDA.reportPublic FDA data

ORPHENADRINE CITRATE

Substance profile for UNII X0A40N8I4S, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ORPHENADRINE CITRATE
Structure render from PubChem CID 83823

Substance Identity#

UNII
X0A40N8I4S
Preferred term
ORPHENADRINE CITRATE
Registry number
4682-36-4
EC number
225-137-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C18H23NO.C6H8O7
Chemical structure for ORPHENADRINE CITRATE
Structure render from PubChem CID 83823

Chemical And Database Identifiers#

SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2C
RxCUI
7716
PubChem
83823
NCIt
C47641
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound83823pubchem.ncbi.nlm.nih.gov/compound/83823
RxNorm7716mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=7716
NCI ThesaurusC47641ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47641
FDA Substance Registration SystemX0A40N8I4Sprecision.fda.gov/uniisearch/srs/unii/X0A40N8I4S
European Community number225-137-5commonchemistry.cas.org/results?q=225-137-5

DailyMed Socrata Ingredients#

DailyMed label, SPL version table
DailyMed labelSPL version
Orphenadrine Citrate Extended-Release Tablets1
Orphenadrine Citrate Extended-Release Tablets Gavis Pharmaceuticals, LLC.1
Orphenadrine Citrate Extended-Release Tablets Gavis Pharmaceuticals, LLC.2
Orphenadrine Citrate Extended-Release Tablets Gavis Pharmaceuticals, LLC.2
Orphenadrine Citrate Extended-Release Tablets1
Orphenadrine Citrate Extended-release Tablets, 100 mg1
Orphenadrine Citrate Extended-release Tablets, 100 mg2
e506b8dc-36b3-44f2-9fd6-316233efeb8b1
Orphenadrine Citrate Extended-Release Tablets1
Orphenadrine Citrate, Aspirin and Caffeine Tablets1
Orphenadrine Citrate Extended-Release Tablets1
Orphenadrine Citrate Extended-Release Tablets1
ORPHENADRINE CITRATE (ORPHENADRINE CITRATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]3221
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]16
ORPHENADRINE CITRATE TABLET [EON LABS, INC.]14
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [GAVIS PHARMACEUTICALS, LLC]12
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.]11
NORGESIC (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE) TABLET, MULTILAYER NORGESIC FORTE (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE) TABLET, MULTILAYER [3M PHARMACEUTICALS]4
ORPHENADRINE CITRATE INJECTION [WATSON LABORATORIES, INC.]4
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PREFERRED PHARMACEUTICALS, INC.]3
ORPHENADRINE CITRATE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS]2
ORPHENADRINE CITRATE TABLET [CARILION MATERIALS MANAGEMENT]2
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK]2
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [CLINICAL SOLUTIONS WHOLESALE]2
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [DIRECT RX]2
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES INC.]2
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [PROFICIENT RX LP]2
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [UNIT DOSE SERVICES]2
NORFLEX (ORPHENADRINE CITRATE) TABLET, EXTENDED RELEASE NORFLEX (ORPHENADRINE CITRATE) INJECTION [3M PHARMACEUTICALS]1
ORPHENADRINE CITRATE INJECTION [AKORN, INC.]1
ORPHENADRINE CITRATE TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]1
ORPHENADRINE CITRATE TABLET [PREFERRED PHARMACEUTICALS, INC.]1
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [A-S MEDICATION SOLUTIONS LLC]1
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [AMERICAN HEALTH PACKAGING]1
ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [AVKARE, INC.]1